Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Animal models in influenza vaccine testing.

van der Laan JW, Herberts C, Lambkin-Williams R, Boyers A, Mann AJ, Oxford J.

Expert Rev Vaccines. 2008 Aug;7(6):783-93. doi: 10.1586/14760584.7.6.783. Review.

PMID:
18665776
2.

Animal models for the preclinical evaluation of candidate influenza vaccines.

Bodewes R, Rimmelzwaan GF, Osterhaus AD.

Expert Rev Vaccines. 2010 Jan;9(1):59-72. doi: 10.1586/erv.09.148. Review.

PMID:
20021306
3.
5.

Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data.

Leroux-Roels G.

Expert Opin Biol Ther. 2009 Aug;9(8):1057-71. doi: 10.1517/14712590903066695. Review.

PMID:
19555313
6.

Progress with human H5N1 vaccines: a perspective from industry.

Palache B, Krause R.

Expert Rev Vaccines. 2009 Apr;8(4):391-400. doi: 10.1586/erv.09.16. Review.

PMID:
19348556
7.

Development of a vaccine against pandemic influenza viruses: current status and perspectives.

Ilyinskii PO, Thoidis G, Shneider AM.

Int Rev Immunol. 2008;27(6):392-426. doi: 10.1080/08830180802295765. Review.

PMID:
19065349
8.

Current status and progress of prepandemic and pandemic influenza vaccine development.

Leroux-Roels I, Leroux-Roels G.

Expert Rev Vaccines. 2009 Apr;8(4):401-23. doi: 10.1586/erv.09.15. Review.

PMID:
19348557
9.

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.

Rimmelzwaan GF, Sutter G.

Expert Rev Vaccines. 2009 Apr;8(4):447-54. doi: 10.1586/erv.09.4. Review.

PMID:
19348560
10.

Emulsion-based adjuvants for influenza vaccines.

Vogel FR, Caillet C, Kusters IC, Haensler J.

Expert Rev Vaccines. 2009 Apr;8(4):483-92. doi: 10.1586/erv.09.5. Review.

PMID:
19348563
11.

Correlates of protection: novel generations of influenza vaccines.

Rimmelzwaan GF, McElhaney JE.

Vaccine. 2008 Sep 12;26 Suppl 4:D41-4. Review.

PMID:
19230158
12.

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF.

Hum Vaccin. 2009 Mar;5(3):126-35. Epub 2009 Mar 15. Review.

PMID:
18948744
13.

Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses.

Belser JA, Szretter KJ, Katz JM, Tumpey TM.

Adv Virus Res. 2009;73:55-97. doi: 10.1016/S0065-3527(09)73002-7. Review.

PMID:
19695381
14.

Influenza A (H5N1) pandemic prototype vaccine Fluval.

Vajo Z.

Expert Rev Vaccines. 2009 May;8(5):619-24. doi: 10.1586/erv.09.25. Review.

PMID:
19397418
15.

Of chickens and men: avian influenza in humans.

Michaelis M, Doerr HW, Cinatl J Jr.

Curr Mol Med. 2009 Mar;9(2):131-51. Review.

PMID:
19275623
16.

Animal models for evaluation of influenza vaccines.

Tripp RA, Tompkins SM.

Curr Top Microbiol Immunol. 2009;333:397-412. doi: 10.1007/978-3-540-92165-3_19. Review.

PMID:
19768416
17.

The role and contributions of systems biology to the non-human primate model of influenza pathogenesis and vaccinology.

Baskin C.

Curr Top Microbiol Immunol. 2013;363:69-85. doi: 10.1007/82_2012_248. Review.

PMID:
22890718
18.

Modeling human influenza infection in the laboratory.

Radigan KA, Misharin AV, Chi M, Budinger GS.

Infect Drug Resist. 2015 Aug 31;8:311-20. eCollection 2015. Review.

Supplemental Content

Support Center